MedPath

DURAMED RESEARCH

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Comparison of DR-2011 to a Progesterone Vaginal Gel for Luteal Phase Replacement

Phase 2
Completed
Conditions
Infertility
Interventions
First Posted Date
2005-07-07
Last Posted Date
2014-05-12
Lead Sponsor
Duramed Research
Target Recruit Count
20
Registration Number
NCT00117468
Locations
🇺🇸

Duramed Investigational Site, Norfolk, Virginia, United States

Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic Pain

Phase 2
Completed
Conditions
Endometriosis
Interventions
Drug: DR-2001a
Drug: DR-2001b
Other: Placebo
First Posted Date
2005-07-07
Last Posted Date
2014-05-09
Lead Sponsor
Duramed Research
Target Recruit Count
90
Registration Number
NCT00117481
Locations
🇺🇸

Duramed Investigational Site, Virginia Beach, Virginia, United States

A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens

Phase 3
Completed
Conditions
Healthy
Interventions
First Posted Date
2005-07-06
Last Posted Date
2014-05-09
Lead Sponsor
Duramed Research
Target Recruit Count
36
Registration Number
NCT00117273
Locations
🇺🇸

Duramed Investigational Site, Temple, Texas, United States

Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral Density

Phase 3
Withdrawn
Conditions
Osteopenia
First Posted Date
2005-07-06
Last Posted Date
2013-08-12
Lead Sponsor
Duramed Research
Registration Number
NCT00117260
© Copyright 2025. All Rights Reserved by MedPath